Inheritance of Epigenetic Aberrations (Constitutional Epimutations) in Cancer Susceptibility

Advances in Genetics

Volumn 70, Issue C, 2010, Pages 201-243

  Hitchins, Megan P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI PROTEIN; AGOUTI SIGNALING PROTEIN, MOUSE; MICRORNA; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN MSH2; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER; NONAGOUTI PROTEIN, MOUSE;

ALPHA THALASSEMIA; ANIMAL; BOOK; FEMALE; GENE SILENCING; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; LINARIA; MALE; METHYLATION; MISMATCH REPAIR; MOUSE; NEOPLASM; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGOUTI SIGNALING PROTEIN; ALPHA-THALASSEMIA; ANIMALS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; EPIGENESIS, GENETIC; FEMALE; GENE SILENCING; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINARIA; MALE; METHYLATION; MICE; MICRORNAS; MUTS HOMOLOG 2 PROTEIN; NEOPLASMS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR MARKERS, BIOLOGICAL;

EID: 77957374539     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-380866-0.60008-3     Document Type: Book

References (75)

1. Barbour V.M., Tufarelli C., Sharpe J.A., Smith Z.E., Ayyub H., Heinlein C.A., Sloane-Stanley J., Indrak K., Wood W.G., Higgs D.R. Alpha-thalassemia resulting from a negative chromosomal position effect. Blood 2000, 96(3):800-807.
2. Blewitt M.E., Vickaryous N.K., Paldi A., Koseki H., Whitelaw E. Dynamic reprogramming of DNA methylation at an epigenetically sensitive allele in mice. PLoS Genet. 2006, 2(4):e49.
3. Bliek J., Alders M., Maas S.M., Oostra R.J., Mackay D.M., Van Der Lip K., Callaway J.L., Brooks A., Van 'T Padje S., Westerveld A., et al. Lessons from bws twins: Complex maternal and paternal hypomethylation and a common source of haematopoietic stem cells. Eur. J. Hum. Genet. 2009, 17(12):1625-1634.
4. Boland C.R., Thibodeau S.N., Hamilton S.R., Sidransky D., Eshleman J.R., Burt R.W., Meltzer S.J., Rodriguez-Bigas M.A., Fodde R., Ranzani G.N., et al. A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998, 58(22):5248-5257.
5. Brown J.R. Inherited predisposition to chronic lymphocytic leukemia. Expert Rev. Hematol. 2008, 1(1):51-61.
6. Buiting K., Dittrich B., Gross S., Lich C., Farber C., Buchholz T., Smith E., Reis A., Burger J., Nothen M.M., et al. Sporadic imprinting defects in prader-willi syndrome and angelman syndrome: Implications for imprint-switch models, genetic counseling, and prenatal diagnosis. Am. J. Hum. Genet. 1998, 63(1):170-180.
7. Chai H., Brown R.E. Field effect in cancer-an update. Ann. Clin. Lab. Sci. 2009, 39(4):331-337.
8. Chan T.L., Yuen S.T., Kong C.K., Chan Y.W., Chan A.S., Ng W.F., Tsui W.Y., Lo M.W., Tam W.Y., Li V.S., et al. Heritable germline epimutation of msh2 in a family with hereditary nonpolyposis colorectal cancer. Nat. Genet. 2006, 38(10):1178-1183.
9. Chong S., Youngson N.A., Whitelaw E. Heritable germline epimutation is not the same as transgenerational epigenetic inheritance. Nat. Genet. 2007, 39(5):574-575. author reply 575-576.
10. Cubas P., Vincent C., Coen E. An epigenetic mutation responsible for natural variation in floral symmetry. Nature 1999, 401(6749):157-161.
11. Cunningham J.M., Christensen E.R., Tester D.J., Kim C.Y., Roche P.C., Burgart L.J., Thibodeau S.N. Hypermethylation of the hmlh1 promoter in colon cancer with microsatellite instability. Cancer Res. 1998, 58(15):3455-3460.
12. Davis T.L., Yang G.J., Mccarrey J.R., Bartolomei M.S. The h19 methylation imprint is erased and re-established differentially on the parental alleles during male germ cell development. Hum. Mol. Genet. 2000, 9(19):2885-2894.
13. De Greef J.C., Lemmers R.J., Van Engelen B.G., Sacconi S., Venance S.L., Frants R.R., Tawil R., Van Der Maarel S.M. Common epigenetic changes of d4z4 in contraction-dependent and contraction-independent fshd. Hum. Mutat. 2009, 30(10):1449-1459.
14. Dion V., Wilson J.H. Instability and chromatin structure of expanded trinucleotide repeats. Trends Genet. 2009, 25(7):288-297.
15. Gazzoli I., Loda M., Garber J., Syngal S., Kolodner R.D. A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the mlh1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res. 2002, 62(14):3925-3928.
16. Geuns E., De Rycke M., Van Steirteghem A., Liebaers I. Methylation imprints of the imprint control region of the snrpn-gene in human gametes and preimplantation embryos. Hum. Mol. Genet. 2003, 12(22):2873-2879.
17. Gicquel C., Rossignol S., Cabrol S., Houang M., Steunou V., Barbu V., Danton F., Thibaud N., Le Merrer M., Burglen L., et al. Epimutation of the telomeric imprinting center region on chromosome 11p15 in silver-russell syndrome. Nat. Genet. 2005, 37(9):1003-1007.
18. Goel A., Nguyen T.P., Leung H.C., Nagasaka T., Rhees J., Hotchkiss E., Arnold M., Banerji P., Koi M., Kwok C.T., et al. De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic lynch syndrome cases, with derivation of the epimutation on the paternal allele in one. Int. J. Cancer 2010, (in press).
19. Grabowski M., Mueller-Koch Y., Grasbon-Frodl E., Koehler U., Keller G., Vogelsang H., Dietmaier W., Kopp R., Siebers U., Schmitt W., et al. Deletions account for 17% of pathogenic germline alterations in mlh1 and msh2 in hereditary nonpolyposis colorectal cancer (hnpcc) families. Genet. Test. 2005, 9(2):138-146.
20. Guilford P., Hopkins J., Harraway J., Mcleod M., Mcleod N., Harawira P., Taite H., Scoular R., Miller A., Reeve A.E. E-cadherin germline mutations in familial gastric cancer. Nature 1998, 392(6674):402-405.
21. Gylling A., Ridanpaa M., Vierimaa O., Aittomaki K., Avela K., Kaariainen H., Laivuori H., Poyhonen M., Sallinen S.L., Wallgren-Pettersson C., et al. Large genomic rearrangements and germline epimutations in lynch syndrome. Int. J. Cancer 2009, 124(10):2333-2340.
22. Hemminki A., Peltomaki P., Mecklin J.P., Jarvinen H., Salovaara R., Nystrom-Lahti M., De La Chapelle A., Aaltonen L.A. Loss of the wild type mlh1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nat. Genet. 1994, 8(4):405-410.
23. Hendriks Y., Franken P., Dierssen J.W., De Leeuw W., Wijnen J., Dreef E., Tops C., Breuning M., Brocker-Vriends A., Vasen H., et al. Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors. Am. J. Pathol. 2003, 162(2):469-477.
24. Herman J.G., Umar A., Polyak K., Graff J.R., Ahuja N., Issa J.P., Markowitz S., Willson J.K., Hamilton S.R., Kinzler K.W., et al. Incidence and functional consequences of hmlh1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA 1998, 95(12):6870-6875.
25. Hitchins M.P., Ward R.L. Erasure of mlh1 methylation in spermatozoa-implications for epigenetic inheritance. Nat. Genet. 2007, 39(11):1289.
26. Hitchins M.P., Ward R.L. Constitutional (germline) mlh1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer. J. Med. Genet. 2009, 46:793-802.
27. Hitchins M., Williams R., Cheong K., Halani N., Lin V.A., Packham D., Ku S., Buckle A., Hawkins N., Burn J., et al. Mlh1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterology 2005, 129(5):1392-1399.
28. Hitchins M.P., Wong J.J., Suthers G., Suter C.M., Martin D.I., Hawkins N.J., Ward R.L. Inheritance of a cancer-associated mlh1 germ-line epimutation. N. Engl. J. Med. 2007, 356(7):697-705.
29. Holliday R. The inheritance of epigenetic defects. Science 1987, 238(4824):163-170.
30. Jass J.R. Heredity and DNA methylation in colorectal cancer. Gut 2007, 56(1):154-155.
31. Knudson A.G. Hereditary cancer: Two hits revisited. J. Cancer Res. Clin. Oncol. 1996, 122(3):135-140.
32. Kolodner R.D. Mismatch repair: Mechanisms and relationship to cancer susceptibility. Trends Biochem. Sci. 1995, 20(10):397-401.
33. Kovacs M.E., Papp J., Szentirmay Z., Otto S., Olah E. Deletions removing the last exon of tacstd1 constitute a distinct class of mutations predisposing to lynch syndrome. Hum. Mutat. 2009, 30(2):197-203.
34. Lane N., Dean W., Erhardt S., Hajkova P., Surani A., Walter J., Reik W. Resistance of iaps to methylation reprogramming may provide a mechanism for epigenetic inheritance in the mouse. Genesis 2003, 35(2):88-93.
35. Ligtenberg M.J., Kuiper R.P., Chan T.L., Goossens M., Hebeda K.M., Voorendt M., Lee T.Y., Bodmer D., Hoenselaar E., Hendriks-Cornelissen S.J., et al. Heritable somatic methylation and inactivation of msh2 in families with lynch syndrome due to deletion of the 3' exons of tacstd1. Nat. Genet. 2009, 41(1):112-117.
36. Lindor N.M., Burgart L.J., Leontovich O., Goldberg R.M., Cunningham J.M., Sargent D.J., Walsh-Vockley C., Petersen G.M., Walsh M.D., Leggett B.A., et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J. Clin. Oncol. 2002, 20(4):1043-1048.
37. Linnaeus C. De peloria 1749, Ph. D thesis, Amoenitates Academy, Uppsala, Sweden.
38. Loesch D.Z., Bui Q.M., Huggins R.M., Mitchell R.J., Hagerman R.J., Tassone F. Transcript levels of the intermediate size or grey zone fragile x mental retardation 1 alleles are raised, and correlate with the number of cgg repeats. J. Med. Genet. 2007, 44(3):200-204.
39. Lucifero D., Mann M.R., Bartolomei M.S., Trasler J.M. Gene-specific timing and epigenetic memory in oocyte imprinting. Hum. Mol. Genet. 2004, 13(8):839-849.
40. Luo D., Carpenter R., Copsey L., Vincent C., Clark J., Coen E. Control of organ asymmetry in flowers of antirrhinum. Cell 1999, 99(4):367-376.
41. Lynch H.T. Hereditary nonpolyposis colorectal cancer (hnpcc). Cytogenet. Cell Genet. 1999, 86(2):130-135.
42. Lynch H.T., Lynch J.F. Lynch syndrome: History and current status. Dis. Markers 2004, 20(4-5):181-198.
43. Mackay D.J., Hahnemann J.M., Boonen S.E., Poerksen S., Bunyan D.J., White H.E., Durston V.J., Thomas N.S., Robinson D.O., Shield J.P., et al. Epimutation of the tndm locus and the beckwith-wiedemann syndrome centromeric locus in individuals with transient neonatal diabetes mellitus. Hum. Genet. 2006, 119(1-2):179-184.
44. Miolo G., Canzonieri V., De Giacomi C., Puppa L.D., Dolcetti R., Lombardi D., Perin T., Scalone S., Veronesi A., Viel A. Selecting for brca1 testing using a combination of homogeneous selection criteria and immunohistochemical characteristics of breast cancers. BMC Cancer 2009, 9:360.
45. Miyakura Y., Sugano K., Akasu T., Yoshida T., Maekawa M., Saitoh S., Sasaki H., Nomizu T., Konishi F., Fujita S., et al. Extensive but hemiallelic methylation of the hmlh1 promoter region in early-onset sporadic colon cancers with microsatellite instability. Clin. Gastroenterol. Hepatol. 2004, 2(2):147-156.
46. Morak M., Schackert H.K., Rahner N., Betz B., Ebert M., Walldorf C., Royer-Pokora B., Schulmann K., Von Knebel-Doeberitz M., Dietmaier W., et al. Further evidence for heritability of an epimutation in one of 12 cases with mlh1 promoter methylation in blood cells clinically displaying hnpcc. Eur. J. Hum. Genet. 2008, 16(7):804-811.
47. Morgan H.D., Sutherland H.G., Martin D.I., Whitelaw E. Epigenetic inheritance at the agouti locus in the mouse. Nat. Genet. 1999, 23(3):314-318.
48. Morgan H.D., Dean W., Coker H.A., Reik W., Petersen-Mahrt S.K. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: Implications for epigenetic reprogramming. J. Biol. Chem. 2004, 279(50):52353-52360.
49. Morgan H.D., Santos F., Green K., Dean W., Reik W. Epigenetic reprogramming in mammals. Hum Mol Genet 2005, 14(Spec. No. 1):R47-R58.
50. Niessen R.C., Hofstra R.M., Westers H., Ligtenberg M.J., Kooi K., Jager P.O., De Groote M.L., Dijkhuizen T., Olderode-Berends M.J., Hollema H., et al. Germline hypermethylation of mlh1 and epcam deletions are a frequent cause of lynch syndrome. Genes Chromosomes Cancer 2009, 48(8):737-744.
51. Oliveira C., Sousa S., Pinheiro H., Karam R., Bordeira-Carrico R., Senz J., Kaurah P., Carvalho J., Pereira R., Gusmao L., et al. Quantification of epigenetic and genetic 2nd hits in cdh1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 2009, 136(7):2137-2148.
52. Peltomaki P., Vasen H. Mutations associated with hnpcc predisposition-update of icg-hnpcc/insight mutation database. Dis. Markers 2004, 20(4-5):269-276.
53. Peto J., Collins N., Barfoot R., Seal S., Warren W., Rahman N., Easton D.F., Evans C., Deacon J., Stratton M.R. Prevalence of brca1 and brca2 gene mutations in patients with early-onset breast cancer. J. Natl. Cancer Inst. 1999, 91(11):943-949.
54. Pharoah P.D., Guilford P., Caldas C. Incidence of gastric cancer and breast cancer in cdh1 (e-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001, 121(6):1348-1353.
55. Pinheiro H., Bordeira-Carrico R., Seixas S., Carvalho J., Senz J., Oliveira P., Inacio P., Gusmao L., Rocha J., Huntsman D., et al. Allele-specific cdh1 downregulation and hereditary diffuse gastric cancer. Hum. Mol. Genet. 2010, 19(5):943-952.
56. Rakyan V.K., Chong S., Champ M.E., Cuthbert P.C., Morgan H.D., Luu K.V., Whitelaw E. Transgenerational inheritance of epigenetic states at the murine axin(fu) allele occurs after maternal and paternal transmission. Proc. Natl. Acad. Sci. USA 2003, 100(5):2538-2543.
57. Raval A., Tanner S.M., Byrd J.C., Angerman E.B., Perko J.D., Chen S.S., Hackanson B., Grever M.R., Lucas D.M., Matkovic J.J., et al. Downregulation of death-associated protein kinase 1 (dapk1) in chronic lymphocytic leukemia. Cell 2007, 129(5):879-890.
58. Santos F., Hendrich B., Reik W., Dean W. Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev. Biol. 2002, 241(1):172-182.
59. Sassone-Corsi P. Unique chromatin remodeling and transcriptional regulation in spermatogenesis. Science 2002, 296(5576):2176-2178.
60. Slaughter D.P., Southwick H.W., Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953, 6(5):963-968.
61. Snell C., Krypuy M., Wong E.M., Loughrey M.B., Dobrovic A. Brca1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a brca1 tumour phenotype. Breast Cancer Res. 2008, 10(1):R12.
62. Stoger R., Kajimura T.M., Brown W.T., Laird C.D. Epigenetic variation illustrated by DNA methylation patterns of the fragile-x gene fmr1. Hum. Mol. Genet. 1997, 6(11):1791-1801.
63. Suter C.M., Martin D.I., Ward R.L. Germline epimutation of mlh1 in individuals with multiple cancers. Nat. Genet. 2004, 36(5):497-501.
64. Tomlinson I.P., Roylance R., Houlston R.S. Two hits revisited again. J. Med. Genet. 2001, 38(2):81-85.
65. Tufarelli C., Stanley J.A., Garrick D., Sharpe J.A., Ayyub H., Wood W.G., Higgs D.R. Transcription of antisense rna leading to gene silencing and methylation as a novel cause of human genetic disease. Nat. Genet. 2003, 34(2):157-165.
66. Umar A., Boland C.R., Terdiman J.P., Syngal S., De La Chapelle A., Ruschoff J., Fishel R., Lindor N.M., Burgart L.J., Hamelin R., et al. Revised bethesda guidelines for hereditary nonpolyposis colorectal cancer (lynch syndrome) and microsatellite instability. J. Natl. Cancer Inst. 2004, 96(4):261-268.
67. Valle L., Carbonell P., Fernandez V., Dotor A.M., Sanz M., Benitez J., Urioste M. Mlh1 germline epimutations in selected patients with early-onset non-polyposis colorectal cancer. Clin. Genet. 2007, 71(3):232-237.
68. Van Overveld P.G., Lemmers R.J., Sandkuijl L.A., Enthoven L., Winokur S.T., Bakels F., Padberg G.W., Van Ommen G.J., Frants R.R., Van Der Maarel S.M. Hypomethylation of d4z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat. Genet. 2003, 35(4):315-317.
69. Vasen H.F., Mecklin J.P., Khan P.M., Lynch H.T. The international collaborative group on hereditary non-polyposis colorectal cancer (icg-hnpcc). Dis. Colon Rectum 1991, 34(5):424-425.
70. Whitelaw N.C., Whitelaw E. Transgenerational epigenetic inheritance in health and disease. Curr. Opin. Genet. Dev. 2008, 18(3):273-279.
71. Xing Y., Shi S., Le L., Lee C.A., Silver-Morse L., Li W.X. Evidence for transgenerational transmission of epigenetic tumor susceptibility in Drosophila. PLoS Genet. 2007, 3(9):1598-1606.
72. Yamazawa K., Kagami M., Fukami M., Matsubara K., Ogata T. Monozygotic female twins discordant for silver-russell syndrome and hypomethylation of the h19-dmr. J. Hum. Genet. 2008, 53(10):950-955.
73. Yu W., Gius D., Onyango P., Muldoon-Jacobs K., Karp J., Feinberg A.P., Cui H. Epigenetic silencing of tumour suppressor gene p15 by its antisense rna. Nature 2008, 451(7175):202-206.
74. Yuille M.R., Matutes E., Marossy A., Hilditch B., Catovsky D., Houlston R.S. Familial chronic lymphocytic leukaemia: A survey and review of published studies. Br. J. Haematol. 2000, 109(4):794-799.
75. Zhou H.H., Yan S.Y., Zhou X.Y., Du X., Zhang T.M., Cai X., Lu Y.M., Cai S.J., Shi D.R. Mlh1 promoter germline-methylation in selected probands of chinese hereditary non-polyposis colorectal cancer families. World J. Gastroenterol. 2008, 14(48):7329-7334.